Growing community of inventors

Burlington, MA, United States of America

Laurent Jean-Claude Bagnol

Average Co-Inventor Count = 10.00

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 38

Laurent Jean-Claude BagnolAles Medek (3 patents)Laurent Jean-Claude BagnolEleni Dokou (3 patents)Laurent Jean-Claude BagnolLori Ann Ferris (3 patents)Laurent Jean-Claude BagnolDragutin Knezic (3 patents)Laurent Jean-Claude BagnolKatie McCarty (3 patents)Laurent Jean-Claude BagnolBrian Dean Phenix (3 patents)Laurent Jean-Claude BagnolGeoffrey Glen Brodeur (3 patents)Laurent Jean-Claude BagnolSachin Chandran (3 patents)Laurent Jean-Claude BagnolSara A Waggener (3 patents)Laurent Jean-Claude BagnolKatie Lynn Mccarty (0 patent)Laurent Jean-Claude BagnolKatie Lynn Mccarty (0 patent)Laurent Jean-Claude BagnolLaurent Jean-Claude Bagnol (3 patents)Ales MedekAles Medek (22 patents)Eleni DokouEleni Dokou (12 patents)Lori Ann FerrisLori Ann Ferris (11 patents)Dragutin KnezicDragutin Knezic (9 patents)Katie McCartyKatie McCarty (5 patents)Brian Dean PhenixBrian Dean Phenix (3 patents)Geoffrey Glen BrodeurGeoffrey Glen Brodeur (3 patents)Sachin ChandranSachin Chandran (3 patents)Sara A WaggenerSara A Waggener (3 patents)Katie Lynn MccartyKatie Lynn Mccarty (0 patent)Katie Lynn MccartyKatie Lynn Mccarty (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Vertex Pharmaceuticals, Inc. (3 from 1,149 patents)


3 patents:

1. 11951212 - Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases

2. 10980746 - Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases

3. 10206877 - Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/5/2025
Loading…